Brand-Name GLP-1 Patient Savings Card Comparison 2026

Published: June 16, 2026 · Last reviewed: June 16, 2026

By The RX Index Editorial Team

Some provider links on this page are sponsored, and we may earn a commission if you start care through one. Manufacturer savings cards are free and come straight from the drugmaker — those links are never sponsored, and commissions never change what we recommend.

The $25 price on a brand-name GLP-1 patient savings card is real — but it’s conditional. In this 2026 comparison, every major card (Wegovy, Zepbound, Foundayo, Ozempic, and Mounjaro) can drop your cost to about $25 a month — but only when you have commercial insurance and your plan covers that exact drug. If your plan doesn’t cover it, there are separate self-pay prices. If you’re on Medicare or Medicaid, a regular card won’t work for you at all — but a new $50 Medicare GLP-1 Bridge launches July 1, 2026.

If you’ve seen the “as little as $25” ad and wondered whether it’s real or bait, here’s the honest answer: it’s real — it’s just conditional. The thing that actually decides your price isn’t the coupon. Find your lane below, then we’ll show you the one thing worth checking before you fill a single prescription.

Find your lane in 10 seconds

Which brand-name GLP-1 savings card is best in 2026?

For weight loss, the three cards worth comparing first are Foundayo, Wegovy, and Zepbound, because those are the GLP-1s the FDA has approved for weight management. Ozempic and Mounjaro have cards too, but they’re diabetes drugs and their cards require a diabetes prescription. The “best” card depends less on the drug name and more on whether your plan covers it.

When your plan covers the drug, all of these cards land you in about the same place — roughly $25 a month. So crowning one “winner” on the $25 number alone is almost pointless. The real differences show up in two places: how big the monthly savings cap is, and what the price falls back to if your plan doesn’t cover the drug.

Skip the trophy and think by your situation:

• If your plan covers the drug: Foundayo, Wegovy, or Zepbound can all get you near $25. Pick with your prescriber based on what fits your body and health history — not the coupon.
• If your plan doesn’t cover it (or you’re paying cash): Foundayo has the lowest published brand-name starting price right now — about $149/month to self-pay through LillyDirect. That makes it the strongest “coverage is uncertain” pick on price alone.
• If you have type 2 diabetes: Ozempic and Mounjaro belong in your comparison — but as diabetes drugs, not a weight-loss shortcut. More on why that matters below.
• If you’re on Medicare: skip the regular cards. The new Bridge gives you a flat $50 a month for Wegovy, Foundayo, or the Zepbound KwikPen starting July 1, 2026.

Brand-Name GLP-1 Patient Savings Card Comparison 2026: the full table

Every brand-name GLP-1 savings card shares one core rule: it drops your cost to about $25 a month when your commercial plan covers the drug, and it does nothing on government insurance. What changes from card to card is the savings cap, whether a diabetes diagnosis is required, and the cash price if your plan won’t cover it.

We pulled the numbers below straight from each drugmaker’s official savings pages.

The one thing that decides your price

A manufacturer savings card is not insurance, and the headline “$25” only applies if your commercial plan actually covers the drug. If your plan excludes it — which many employer plans still do for weight-loss drugs — the card’s help shrinks. And if you’re on any government plan, federal law blocks the card entirely. So the real question isn’t “which coupon.” It’s “can I get covered.”

The drugmaker’s ad can be 100% true, the card can work exactly as designed — and you can still pay more than $25. That’s not a scam. That’s the cap meeting your copay. Any page that shouts “as little as $25” without showing you this math is leaving you half-informed.

If your plan covers your drug, you’re basically done — grab the card. If it doesn’t, don’t give up. The next sections show you how to get covered, and the cash options if you can’t.

Do you actually qualify for a $25 GLP-1 savings card?

You usually qualify if you’re a U.S. adult, you have a valid prescription, you have commercial insurance, and your plan covers that exact drug. You’re shut out if you have Medicare, Medicaid, the VA, or TRICARE — that’s a federal rule, not the drugmaker being difficult. There’s no income limit on the card itself; the gate is your insurance type.

Run yourself through this checklist:

1. You have a prescription for the drug’s FDA-approved use.
2. You’re 18 or older and live in the U.S. (or Puerto Rico, where the card allows).
3. You have commercial drug insurance.
4. Your plan covers that medication — or the card has a separate, smaller “not-covered” offer.
5. You’re not on a government plan.

Why “as little as $25” doesn’t always mean you’ll pay $25

“As little as $25” means $25 is the lowest price you could get — not the price you will get. Every card has a cap, which is the most it will pay for you each month. If your insurance copay is higher than that cap, you pay the difference. So the card can work perfectly and you can still pay more than $25.

Here’s the math that actually changes your bill:

Same card. Same rules. Wildly different price — because your plan’s copay is what decides it. This matters more in 2026 because the weight-loss cards cap monthly savings around $100. Lilly’s Zepbound card, for example, lists a $100-per-month savings cap and a $1,300-per-year maximum for covered commercial patients.

So when your number isn’t $25, it’s almost never the coupon’s fault. It’s usually one of two things: your plan doesn’t cover the drug, or a prior authorization is stuck. (Prior authorization — “PA” — is your insurer’s permission slip, an extra OK your doctor sends in before the plan will cover certain drugs.) A denied or missing PA is one of the top reasons people get quoted hundreds instead of $25. The card can’t fix that. Getting the PA approved can.

Diabetes cards vs. weight-loss cards: why Ozempic and Mounjaro are different

Ozempic and Mounjaro are FDA-approved for type 2 diabetes — not weight loss. Their savings cards require a diabetes prescription, and your plan has to be covering the drug for diabetes. The FDA-approved weight-loss brands are Wegovy, Zepbound, and Foundayo. If a doctor prescribed Ozempic or Mounjaro for weight loss, the card terms may not apply, and coverage is unlikely.

This sounds like fine print, but it’s the most expensive mix-up on the topic. Here’s the simple map:

Notice that the famous pairs share a medicine but not a use: semaglutide is in Ozempic, Rybelsus, and Wegovy; tirzepatide is in Mounjaro and Zepbound. Foundayo (orforglipron) is a different molecule. Same medicine does not mean the same prescription, dose, coverage, or savings card.

Want a single-drug deep dive? See our full Ozempic savings card guide and Mounjaro savings card guide for the diabetes side.

Each card up close (the verdict first, then the details)

What to do if your savings card is rejected at the pharmacy

A rejected card doesn’t always mean you don’t qualify. The most common causes are: your plan doesn’t cover the drug, the pharmacy didn’t run the card behind your insurance, you hit a cap, the card expired, or you’re on a government plan. Many of these are fixable on the spot or with one call — but some need a prior authorization, plan coverage, or a different payment lane.

Pharmacy rejection checklist:

1. Confirm the prescription is for the exact drug and form on your card.
2. Confirm the card is activated (some need a quick sign-up first).
3. Ask: “Did you run my insurance first, then the card?”
4. Ask the pharmacist to process the card as a secondary payer (after your insurance).
5. Ask whether your plan covers the drug at all.
6. Ask whether a prior authorization is required and not yet approved.
7. Ask whether you’ve hit a monthly, yearly, or fill limit.
8. Ask whether a plan rule — like a “copay accumulator” — is blocking the card. (A copay accumulator is a plan setting that stops manufacturer card dollars from counting toward your deductible, which can make the card look like it “stopped working.”)
9. Ask whether your plan type is excluded (a government plan will be).
10. Still stuck? Call the manufacturer support number printed on the card.

Then ask the pharmacist to write down the rejection code and which bucket it falls in (coverage, PA, cap, plan type, or accumulator). That one note tells you exactly which fix you need.

Can you use a GLP-1 savings card without insurance?

Usually not — the $25 commercial card needs commercial insurance and drug coverage. If you’re uninsured, or your plan won’t cover the drug, your real options are the drugmaker’s own self-pay programs, the government’s TrumpRx site, and patient-assistance programs if your income is low.

First, an important difference people miss: “my plan doesn’t cover it” is not the same as “I have no insurance.” Some drugmaker offers are written for one and not the other, so read which one applies to you.

Where to look if you’re paying cash:

• LillyDirect (Zepbound, Mounjaro, Foundayo): Zepbound vials $299–$699/month by dose (with the $449 refill offer on higher doses); Foundayo from $149/month.
• NovoCare (Wegovy, Ozempic): the Wegovy pill starts at $149/month and the pen at $199/month intro — and for Wegovy, the uninsured can use the same NovoCare program to get those prices.
• TrumpRx (TrumpRx.gov): a government site that links to direct cash-pay discounts for people not using insurance. Headline prices include the Wegovy pill at $149/month, the Wegovy pen at $199/month, Ozempic at $199/month, and Zepbound at $299/month (Foundayo routes through LillyDirect). These aren’t coupons and don’t need insurance.
• Patient-assistance programs: for low-income uninsured patients, NovoCare runs a program that can provide medication free if you qualify.

If you also still need a prescription, a telehealth provider can bundle the doctor visit with the medication. For paying-cash, brand-name shoppers who want to compare options or check Costco-member pricing on Wegovy and Ozempic, Sesame Care is a solid fit.

Can Medicare, Medicaid, VA, or TRICARE patients use these cards?

No — regular manufacturer savings cards are blocked for everyone on a government plan. But starting July 1, 2026, eligible Medicare Part D members can get Wegovy, the Zepbound KwikPen, or Foundayo for a flat $50 a month through the new Medicare GLP-1 Bridge. The $50 stays the same no matter your dose, and you can’t add a coupon on top of it.

If you’re on Medicare, don’t waste an hour trying to force a commercial card to work. You have your own path now — and it’s genuinely new.

For diabetes GLP-1s like Ozempic and Mounjaro, Medicare Part D has long covered them for diabetes. In 2026, your total out-of-pocket spending on covered drugs is capped at $2,100 for the year.

Can you stack GoodRx, SingleCare, HSA/FSA, and a savings card?

Usually no. A manufacturer card works behind your commercial insurance. GoodRx and SingleCare are cash-discount coupons that replace insurance for that fill. You compare them and pick the lower one — you don’t combine them. And the card terms say you can’t get reimbursed through an HSA or FSA for the savings the card gave you.

Who can help you make a savings card actually work?

A savings card doesn’t prescribe medication, check whether a drug is safe for you, submit a prior authorization, or call your insurer. If you need those steps handled, Ro is the strongest first stop for coverage checks and prior-authorization help, and Sesame is the better option for cash-pay, brand-name shoppers who want provider choice.

Ro — best when coverage is your roadblock

In plain terms: Ro carries Foundayo™, the Wegovy® pill, the Wegovy® pen, the Zepbound® pen, and the Zepbound® KwikPen®, runs a free GLP-1 Insurance Coverage Checker plus an insurance concierge that submits prior-authorization paperwork, and prices its medication to match LillyDirect, NovoCare, and TrumpRx. Membership is $39 for the first month, then $149/month — or as low as $74/month if you prepay for the year — with medication billed separately.

The honest trade-off: Ro is not the rock-bottom cash sticker price, and you don’t need it if your coverage and prescription are already sorted. If paying the absolute lowest price with no membership is your only goal, the drugmaker’s own self-pay program or Sesame’s pay-per-visit option will suit you better. But because Ro bundles the prescriber, the free coverage check, and the prior-authorization help, it’s the right call when “my plan keeps denying it” is your real problem.

Sesame — best for cash-pay, brand-name comparison

Sesame is the better fit if you’re paying cash, want to choose your own provider, and want to compare branded options without making insurance the center of everything. It lists brand-name GLP-1 options and is known for Costco-member pricing on Wegovy and Ozempic. Confirm the current price and any program fee at checkout before you commit.

Why people get blindsided by GLP-1 savings cards

The number-one reason people feel tricked isn’t a scam — it’s the gap between “as little as $25” and what their specific plan charges. Coverage changes, missing prior authorizations, monthly caps, and government-plan exclusions are the usual culprits.

• Someone whose employer plan dropped weight-loss coverage for the new year, so a card that worked in December leaves them paying full price in January.
• Someone who activates a Zepbound or Mounjaro card and gets no discount at the counter — because their plan doesn’t cover the drug, so the covered-tier price never applies.
• Someone on Medicare who assumes a coupon will work, not realizing federal law blocks it.

What changed for GLP-1 savings cards in 2026?

2026 made the old “which coupon is cheapest” question incomplete. A new oral drug (Foundayo) arrived, a new $50 Medicare path opened, and tighter monthly caps mean the headline price matters less than your coverage.

Brand-name GLP-1 savings card FAQs

Short, direct answers to the follow-up questions people ask after comparing cards.